Indegene Limited (IN:INDGN)
:INDGN
Want to see IN:INDGN full AI Analyst Report?
INDGN Stock Chart & Stats
₹522.25
₹9.00(1.45%)
At close: 4:00 PM EST
₹522.25
₹9.00(1.45%)
Day’s Range― - ―
52-Week Range₹414.90 - ₹632.10
Previous CloseN/A
Volume943.30K
Average Volume (3M)17.62K
Market Cap
₹123.91B
Enterprise Value₹121.05B
Total Cash (Recent Filing)₹12.68B
Total Debt (Recent Filing)₹2.10B
Price to Earnings (P/E)32.7
Beta0.49
Next Earnings
Jul 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.38%
Share Statistics
EPS (TTM)18.62
Shares Outstanding240,901,350
10 Day Avg. Volume12,460
30 Day Avg. Volume17,622
Financial Highlights & Ratios
PEG Ratio-10.37
Price to Book (P/B)3.32
Price to Sales (P/S)2.97
P/FCF Ratio16.84
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹600.00Price Target Upside14.89% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)21.34
Revenue Forecast (FY)₹42.77B
Bulls Say, Bears Say
Bulls Say
Consistent Revenue GrowthSustained top-line growth demonstrates repeatable demand for Indegene’s life-sciences commercialization services and scalable delivery model. Durable revenue expansion supports reinvestment in digital platforms and talent, improving market share and long-term client stickiness across product lifecycles.
Conservative Leverage / Strong Balance SheetVery low historical leverage and a materially expanded equity base give the company financial flexibility to fund organic growth, pursue selective M&A, and absorb cyclical shocks. Manageable debt levels reduce refinancing risk and preserve capacity for strategic investments over the medium term.
Strong Free Cash Flow ProfileNear-parity of free cash flow and net income in recent years indicates that earnings translate into cash, supporting sustainable capital allocation for product development, platform scaling and working-capital needs. Persistent FCF cushions variability and underpins longer-term operational resilience.
Bears Say
Volatile Cash ConversionSharp swings in operating cash flow and intermittent negative free cash flow years undermine predictability of internally generated funds. This volatility complicates multi-year planning, could force external financing in weak years, and raises execution risk for sustained investment or payout strategies.
Margin Data Quality IssuesInconsistent margin reporting reduces confidence in assessing operating efficiency and sustainable profitability. If gross/profit margin figures are unreliable, forecasting future margins, benchmarking against peers, and evaluating margin-expansion opportunities become materially harder for investors and management alike.
Negative EPS Growth RecentlyA negative EPS growth metric indicates earnings have not consistently advanced with revenue, suggesting margin pressure, one-offs, or investment-related dilution. Persisting weak EPS trends would limit retained-earnings buildup and could constrain capital returns or raise scrutiny on operational leverage.
Indegene Limited News
INDGN FAQ
What was Indegene Limited’s price range in the past 12 months?
Indegene Limited lowest stock price was ₹414.90 and its highest was ₹632.10 in the past 12 months.
What is Indegene Limited’s market cap?
Indegene Limited’s market cap is ₹123.91B.
When is Indegene Limited’s upcoming earnings report date?
Indegene Limited’s upcoming earnings report date is Jul 30, 2026 which is in 69 days.
How were Indegene Limited’s earnings last quarter?
Indegene Limited released its earnings results on Apr 29, 2026. The company reported ₹3.3 earnings per share for the quarter, missing the consensus estimate of ₹4.55 by -₹1.25.
Is Indegene Limited overvalued?
According to Wall Street analysts Indegene Limited’s price is currently Undervalued.
Does Indegene Limited pay dividends?
Indegene Limited pays a Notavailable dividend of ₹2 which represents an annual dividend yield of 0.38%. See more information on Indegene Limited dividends here
What is Indegene Limited’s EPS estimate?
Indegene Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Indegene Limited have?
Indegene Limited has 240,901,350 shares outstanding.
What happened to Indegene Limited’s price movement after its last earnings report?
Indegene Limited reported an EPS of ₹3.3 in its last earnings report, missing expectations of ₹4.55. Following the earnings report the stock price went down -0.87%.
Which hedge fund is a major shareholder of Indegene Limited?
Currently, no hedge funds are holding shares in IN:INDGN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Indegene Limited
Indegene Limited operates as a life sciences commercialization company in India and internationally. It helps biopharmaceutical, emerging biotech, and medical device companies develop products, get to the market, and grow impact through the life cycle. The company offers enterprise commercial solutions, enterprise medical solutions, enterprise clinical solutions, omnichannel activation solutions, and NEXT technology platforms. The company was incorporated in 1998 and is based in Bengaluru, India.
INDGN Stock 12 Month Forecast
Average Price Target
₹600.00
▲(14.89% Upside)
Technical Analysis
Birlasoft Limited
―
Cyient Limited
―
Latent View Analytics Limited
―
Tanla Platforms Ltd
―
Zensar Technologies Limited
―